Duravyu demonstrated vision improvement in phase 2 trials in patients with diabetic macular edema. Phase 3 trials are enrolling patients now.

New research revealed that many genetic variants linked to inherited retinal diseases rarely cause vision loss, challenging previous assumptions about their impact.

In 2024, U.S. health care spending rose to $5.3 trillion, driven by increased per capita use and demand for medical services as utilization rebounded following the COVID-19 pandemic.

A long-term UK Biobank analysis shows that while early or surgical menopause initially appears linked to higher diabetes rates, this association disappears after accounting for lifestyle and cardiovascular risk factors rather than menopause timing itself.

Carbohydrate counting involves blood glucose checks before and after meals, calculating carbohydrate consumption, and then adjusting insulin accordingly.

Several lines of evidence suggest that testing the traditional drug for diabetes might benefit people with idiopathic pulmonary fibrosis.

Combining NB-UVB light therapy with ruxolitinib cream enhances skin repigmentation in vitiligo patients, showing promising results without safety concerns.

United States health care spending rose to $5.3 trillion in 2024, accounting for 18% of the economy, as strong post-pandemic demand and high insurance coverage continued to drive costs upward.

Beginning this month, PBMs in California must prioritize health plan interests over their own, and CVS Caremark’s CalPERS contract includes $250 million in performance guarantees.